𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of metastatic thyroid carcinoma with I131

✍ Scribed by J.G.M. Klijn; C.M.A. Gears; W.L.J. van Putten; P.H. Cox; J. Alexieva-Figusch

Book ID
116006823
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
114 KB
Volume
28
Category
Article
ISSN
0022-4731

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I/II trial of 131I-MN-14 F(ab)2 an
Phase I/II trial of 131I-MN-14 F(ab)2 anti–carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma
✍ Malik E. Juweid; George Hajjar; Lawrence C. Swayne; Robert M. Sharkey; Samer Sul πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 464 KB πŸ‘ 1 views

## BACKGROUND. Monoclonal antibodies (MAbs) against carcinoembryonic antigen (CEA) have been recognized as targeting agents for medullary thyroid carcinoma (MTC). This Phase I/II study was initiated to determine the safety, maximum tolerated dose (MTD), and therapeutic potential of 131 I-MN-14 F(ab

131I treatment of thyroid papillary carc
131I treatment of thyroid papillary carcinoma in a patient with renal failure
✍ Donald W. Morrish; Larry J. Filipow; Alexander J. McEwan; Ronald Schmidt; Keith πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 503 KB

Procedures for 13'1 ablation in renal failure are not known. In one patient receiving dialysis, detailed dosimetry and health safety aspects were obtained. The results showed insignificant contamination of equipment, but a surprisingly significant reduction in biologic half-life of I3'I due to effic